文献速递临床试验与 GCP

围术期远程缺血调节对不稳定型心绞痛患者经皮冠状动脉介入治疗围术期心肌损伤的影响:多中心、随机、双盲临床试验方案

Effect of perioperative remote ischemic conditioning on myocardial injury in patients with unstable angina undergoing percutaneous coronary intervention: protocol of a multicenter, randomized, double-blind clinical trial.
PubMed 文献 · Trials · 2025-02-21

本方案介绍一项实用性、前瞻性、双中心、双盲、随机对照临床试验,评估远程缺血调节(RIC)对年龄≥18岁接受冠状动脉造影的不稳定型心绞痛患者经皮冠状动脉介入治疗(PCI)围术期心肌损伤的影响。受试者随机接受RIC或假RIC联合标准药物治疗,主要结局为hs-cTnT测量的围术期心肌损伤,计划招募574例,2024年1月15日启动,按意向性治疗原则分析。

要点

  • RIC或假RIC联合标准药物治疗,评估对不稳定型心绞痛患者PCI围术期心肌损伤的影响。
  • 主要结局为hs-cTnT测量的围术期心肌损伤,次要结局包括主要不良心血管事件等。
  • 计划招募574例,2024年1月15日启动,按意向性治疗原则分析。

核心结论

  • RIC被假设为一种有效的协同干预措施,可减少PCI相关并发症,并可能提高PCI手术本身的疗效。

研究设计与样本

  • 实用性、前瞻性、双中心、双盲、随机对照临床试验。
  • 纳入年龄≥18岁接受冠状动脉造影的不稳定型心绞痛患者。
  • 计划招募574例参与者,2024年1月15日启动。
  • 按意向性治疗原则进行主要统计分析,结果按CONSORT指南以比较汇总统计量呈现。
  • 试验注册号ChiCTR2400079855,注册日期2024年1月15日。

关键数值与推荐

  • 主要结局为hs-cTnT测量的围术期心肌损伤。
  • 次要结局包括主要不良心血管事件、冠状动脉病变Gensini评分、心律失常、心绞痛发生率、SAQ评分、心电图改变及二维超声心动图评估的心功能。
  • 干预措施为RIC或假RIC,联合标准药物治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular disease is a leading cause of death, with ischemic heart disease being a significant contributor. While percutaneous coronary intervention (PCI) effectively reduces mortality in myocardial infarction patients, its efficacy for unstable angina (UA) patients is controversial. Complications associated with PCI further limit application in UA. RIC is hypothesized to be an effective co-intervention that reduces PCI-related complications and may potentially enhance the efficacy of the PCI procedure itself. METHODS: This is a pragmatic, prospective, dual-center, double-blind, randomized controlled clinical trial assessing the effect of remote ischemic conditioning (RIC) during percutaneous coronary intervention (PCI) on injury in unstable angina patients aged ≥ 18 years undergoing coronary angiography. Participants will be randomized to receive either RIC or Sham RIC, in addition to standard pharmacotherapy. Primary outcome includes periprocedural myocardial injury measured by hs-cTnT levels, while secondary outcomes encompass major adverse cardiovascular events, coronary artery lesions Gensini Score, arrhythmia, angina incidence, SAQ scores, ECG changes, and cardiac function assessed by two-dimensional echocardiography. The trial aims to recruit 574 participants and is scheduled to be initiated on 15 January 2024. We will conduct the primary statistical analysis using the intention-to-treat principle. Results from the trial will be presented as comparative summary statistics following the Consolidated Standards of Reporting Trials (CONSORT) guidelines. TRIAL REGISTRATION: ChiCTR2400079855, 15 January 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Xia L, Yang Q, Jiang L, et al. Effect of perioperative remote ischemic conditioning on myocardial injury in patients with unstable angina undergoing percutaneous coronary intervention: protocol of a multicenter, randomized, double-blind clinical trial. Trials. 2025. PMID: 39984971. doi:10.1186/s13063-025-08744-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。